open access

Vol 80, No 12 (2022)
Short communication
Published online: 2022-12-27
Get Citation

Maladaptation of the maternal cardiovascular system as a cause of fetal growth restriction: Study rationale and design

Aleksandra Ciepłucha1, Mariola Ropacka-Lesiak2, Sylwia Sławek-Szmyt1, Ludwina Szczepaniak-Chicheł3, Agnieszka Bartczak-Rutkowska1, Natalia Misan2, Andrzej Tykarski3, Maciej Lesiak1, Katarzyna Kawka-Paciorkowska2
Pubmed: 36546599
·
Kardiol Pol 2022;80(12):1263-1265.
Affiliations
  1. 1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland
  2. Department of Perinatology and Gynecology, Poznan University of Medical Sciences, Poznań, Poland
  3. Department of Hypertensiology, Poznan University of Medical Sciences, Poznań, Poland

open access

Vol 80, No 12 (2022)
Short communication
Published online: 2022-12-27

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Maladaptation of the maternal cardiovascular system as a cause of fetal growth restriction: Study rationale and design

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 80, No 12 (2022)

Article type

Short communication

Pages

1263-1265

Published online

2022-12-27

Page views

500

Article views/downloads

54

Pubmed

36546599

Bibliographic record

Kardiol Pol 2022;80(12):1263-1265.

Authors

Aleksandra Ciepłucha
Mariola Ropacka-Lesiak
Sylwia Sławek-Szmyt
Ludwina Szczepaniak-Chicheł
Agnieszka Bartczak-Rutkowska
Natalia Misan
Andrzej Tykarski
Maciej Lesiak
Katarzyna Kawka-Paciorkowska

References (8)
  1. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100): 1151–1210.
  2. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227–3337.
  3. Ukah UV, Auger N. Severe maternal morbidity and risk of cardiovascular disease: Recent advances. Kardiol Pol. 2022; 80(6): 638–643.
  4. Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2020; 223(4): B2–BB17.
  5. Figueras F, Caradeux J, Crispi F, et al. Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol. 2018; 218(2S): S790–S802.e1.
  6. Khalil A, Gordijn SJ, Beune IM, et al. Essential variables for reporting research studies on fetal growth restriction: a Delphi consensus. Ultrasound Obstet Gynecol. 2019; 53(5): 609–614.
  7. Sengupta SP, Bansal M, Hofstra L, et al. Gestational changes in left ventricular myocardial contractile function: new insights from two-dimensional speckle tracking echocardiography. Int J Cardiovasc Imaging. 2017; 33(1): 69–82.
  8. Sławek-Szmyt S, Kawka-Paciorkowska K, Ciepłucha A, et al. Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease-a review. J Clin Med. 2022; 11(20).

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl